COMPASS FINANCIAL MANAGEMENT LLC’s Thermo Fisher Scientific TMO Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.02K	Buy	+16	New	+$7.68K	﹤0.01%	1099

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's TMO Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 16 shares worth $8.02K. The stake represents ﹤0.01% of the portfolio and ranks #1099 among its holdings.

2,089 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 16 shares of Thermo Fisher Scientific worth $8.02K as of Q2 2026.
Thermo Fisher Scientific was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Thermo Fisher Scientific made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1099 holding.
2,089 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.